65 results
8-K
EX-10.1
XSNX
NovAccess Global Inc.
3 May 24
NovAccess Global Announces New License to Advance its Immunotherapy Platform
8:20am
not have a Material Adverse Effect.
s. Environmental Matters.
(i) There are, to the Company’s knowledge, with respect to the Company or any of its … Subsidiaries or any predecessor of the Company, no past or present violations of Environmental Laws (as defined below), releases of any material
8-K
EX-10.1
XSNX
NovAccess Global Inc.
28 Feb 24
Entry into a Material Definitive Agreement
3:06pm
, defaults or violations, which conflicts, defaults or violations would not have a Material Adverse Effect.
s. Environmental Matters.
(i … of Environmental Laws (as defined below), releases of any material into the environment, actions, activities, circumstances, conditions, events, incidents
424B3
XSNX
NovAccess Global Inc.
19 Sep 22
Prospectus supplement
9:16am
to environmental regulatory requirements, and could fail to meet such requirements, and we do not carry insurance against environmental damage or injury … the development, testing, marketing and sale of our biopharmaceuticals. However, compliance with environmental laws is not a significant cost for the Company.
Our
8-K
EX-10.1
8ptf98ux62xsozk
10 May 22
Entry into a Material Definitive Agreement
8:22am
8-K
EX-10.1
j8sfsxt
18 Feb 22
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.1
if01yw3 j56a87yl1
25 Aug 21
Entry into a Material Definitive Agreement
11:53am
D
i8b xwutmb
16 Nov 20
$500K in equity, sold $175K, 4 investors
11:12am
SC 14F1/A
lozuepuqc g1w2fufq2
13 May 20
Statement regarding change in majority of directors (amended)
2:53pm
SC 14F1
ijzy9d
1 May 20
Statement regarding change in majority of directors
4:16pm